Moreover, our additional results showed that DNMT3a in different subsets of patients with ovarian cancer had no effect on the survival status, although DNMT1 expression showed better OS and DFS in patients with large tumors than that in patient with smaller tumors. This evidence concerns the gene DNMT3A and ovarian carcinoma.